Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer (ADCT)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. SPY
6. META
7. BA
8. HOOD
9. INTC
10. JBLU

Go back to Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer (ADCT)

Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer

April 6, 2021 7:00 AM EDT

Senior pharmaceutical executive with deep oncology experience in Asia formerly of Takeda, MSD, Bayer and Pfizer

BOSTON, SHANGHAI & LAUSANNE, Switzerland--(BUSINESS WIRE)-- Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT), today announced the appointment of Eric Koo, BSc, MBA, as Chief Executive Officer. Mr. Koo brings more than 25 years of pharmaceutical industry and business management experience to Overland ADCT BioPharma with a proven track record of executing successful drug approvals and launches across Asia.

This press... More